0001415889-24-030323.txt : 20241231 0001415889-24-030323.hdr.sgml : 20241231 20241231171812 ACCESSION NUMBER: 0001415889-24-030323 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241227 FILED AS OF DATE: 20241231 DATE AS OF CHANGE: 20241231 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hohl Benjamin CENTRAL INDEX KEY: 0001882764 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39247 FILM NUMBER: 241593773 MAIL ADDRESS: STREET 1: 6200 LOOKOUT ROAD CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Enliven Therapeutics, Inc. CENTRAL INDEX KEY: 0001672619 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 811523849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6200 LOOKOUT ROAD CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-647-8519 MAIL ADDRESS: STREET 1: 6200 LOOKOUT ROAD CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: IMARA Inc. DATE OF NAME CHANGE: 20160419 4 1 form4-12312024_101209.xml X0508 4 2024-12-27 0001672619 Enliven Therapeutics, Inc. ELVN 0001882764 Hohl Benjamin C/O ENLIVEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD BOULDER CO 80301 false true false false CHIEF FINANCIAL OFFICER 1 Common Stock 2024-12-27 4 M 0 3350 2.48 A 3350 D Common Stock 2024-12-27 4 S 0 3350 22.1549 D 0 D Common Stock 2024-12-30 4 M 0 900 2.48 A 900 D Common Stock 2024-12-30 4 S 0 900 22.5061 D 0 D Stock Option (right to buy) 2.48 2024-12-27 4 M 0 3350 0 D 2031-08-02 Common Stock 3350 165206 D Stock Option (right to buy) 2.48 2024-12-30 4 M 0 900 0 D 2031-08-02 Common Stock 900 164306 D The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023. This transaction was executed in multiple trades at prices ranging from $21.58 to $22.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $22.50 to $22.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter. /s/ Benjamin Hohl 2024-12-31